198 related articles for article (PubMed ID: 26319115)
1. Botanicals as "new" drugs: US development.
Hoffman FA
Epilepsy Behav; 2015 Nov; 52(Pt B):338-43. PubMed ID: 26319115
[TBL] [Abstract][Full Text] [Related]
2. Examining Manufacturing Readiness for Breakthrough Drug Development.
Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP
AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693
[No Abstract] [Full Text] [Related]
3. Regulatory watch: FDA guidance on co-developing investigational drugs.
Nat Rev Drug Discov; 2011 Feb; 10(2):86. PubMed ID: 21283094
[No Abstract] [Full Text] [Related]
4. Building a drug development database: challenges in reliable data availability.
Audibert C; Romine M; Caze A; Daniel G; Leff J; McClellan M
Drug Dev Ind Pharm; 2017 Jan; 43(1):74-78. PubMed ID: 27494335
[TBL] [Abstract][Full Text] [Related]
5. 2013 FDA drug approvals.
Mullard A
Nat Rev Drug Discov; 2014 Feb; 13(2):85-9. PubMed ID: 24481294
[No Abstract] [Full Text] [Related]
6. Is the priority review voucher program stimulating new drug development for tropical diseases?
Kerr KW; Henry TC; Miller KL
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006695. PubMed ID: 30092022
[TBL] [Abstract][Full Text] [Related]
7. FDA not NIH can speed new drugs.
Miller HI
Nature; 2011 Apr; 472(7342):169. PubMed ID: 21490657
[No Abstract] [Full Text] [Related]
8. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS
Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
[TBL] [Abstract][Full Text] [Related]
9. Accelerating orphan drug development.
Coté TR; Xu K; Pariser AR
Nat Rev Drug Discov; 2010 Dec; 9(12):901-2. PubMed ID: 21119719
[TBL] [Abstract][Full Text] [Related]
10. The 21st Century Cures Act: can the regulatory framework survive the "cures"?
Osorio-de-Castro CG; Caetano R; Pepe VL
Cad Saude Publica; 2015 Sep; 31(9):1807-10. PubMed ID: 26578005
[No Abstract] [Full Text] [Related]
11. Adverse effects in women: implications for drug development and regulatory policies.
Parekh A; Fadiran EO; Uhl K; Throckmorton DC
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):453-66. PubMed ID: 22114855
[TBL] [Abstract][Full Text] [Related]
12. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
Tylenda CA; Weintraub M
Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
[TBL] [Abstract][Full Text] [Related]
13. Raising orphans: how clinical development programs of drugs for rare and common diseases are different.
Orfali M; Feldman L; Bhattacharjee V; Harkins P; Kadam S; Lo C; Ravi M; Shringarpure DT; Mardekian J; Cassino C; Coté T
Clin Pharmacol Ther; 2012 Aug; 92(2):262-4. PubMed ID: 22739137
[TBL] [Abstract][Full Text] [Related]
14. Accelerated approval dust begins to settle.
Mullard A
Nat Rev Drug Discov; 2011 Oct; 10(11):797-8. PubMed ID: 22037027
[No Abstract] [Full Text] [Related]
15. Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation.
Zineh I; Woodcock J
Clin Pharmacol Ther; 2013 Jun; 93(6):515-25. PubMed ID: 23571772
[TBL] [Abstract][Full Text] [Related]
16. Generic drug approval: a US perspective.
Nagori BP; Mathur V; Garg S
Curr Med Res Opin; 2011 Mar; 27(3):541-5. PubMed ID: 21219120
[TBL] [Abstract][Full Text] [Related]
17. The IND application.
Ferkany JW; Williams M
Curr Protoc Pharmacol; 2008 Sep; Chapter 9():Unit 9.10. PubMed ID: 22294234
[TBL] [Abstract][Full Text] [Related]
18. Health, Wealth, and the 21st Century Cures Act.
Lo AW; Philipson TJ; von Eschenbach AC
JAMA Oncol; 2016 Jan; 2(1):17-8. PubMed ID: 26513279
[No Abstract] [Full Text] [Related]
19. Drug development for neglected diseases - the trouble with FDA review vouchers.
Kesselheim AS
N Engl J Med; 2008 Nov; 359(19):1981-3. PubMed ID: 18987367
[No Abstract] [Full Text] [Related]
20. Challenges and opportunities in bringing new medications to market for pediatric patients.
Upadhyaya HP; Gault L; Allen AJ
J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1056-1059. PubMed ID: 19855220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
